Elevated pulmonary tuberculosis biomarker miR-423-5p plays critical role in the occurrence of active TB by inhibiting autophagosome-lysosome fusion

References

• World Health Organization. Global tuberculosis report of 2017; 2017.
   Google Scholar
• Barry CE, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 2009;7:845–855. doi: 10.1038/nrmicro2236
   PubMed Web of Science ®Google Scholar
• Pm S. Tuberculosis: a new vision for the 21st century. Kekkaku. 2009;84:721–726.
   PubMedGoogle Scholar
• Heydari AA, Movahhede Danesh MR, Ghazvini K. Urine PCR evaluation to diagnose pulmonary tuberculosis. Jundishapur J Microbiol. 2014;7:e9311. doi: 10.5812/jjm.9311
   PubMed Web of Science ®Google Scholar
• Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013;13:349–361. doi: 10.1016/S1473-3099(13)70008-2
   PubMed Web of Science ®Google Scholar
• Liu J, Jiang T, Wei L, et al. The discovery and identification of a candidate proteomic biomarker of active tuberculosis. BMC Infect Dis. 2013;13:506. doi: 10.1186/1471-2334-13-506
   PubMed Web of Science ®Google Scholar
• Xu D-D, Deng D-F, Li X, et al. Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS. Proteomics. 2014;14:322–331. doi: 10.1002/pmic.201300383
   PubMed Web of Science ®Google Scholar
• Zhang X, Guo J, Fan S, et al. Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis. Plos One. 2013;8:e81076. doi: 10.1371/journal.pone.0081076
   PubMed Web of Science ®Google Scholar
• Gilad S, Meiri E, Yogev Y, et al. Serum MicroRNAs are promising novel biomarkers. Plos One. 2008;3:e3148. doi: 10.1371/journal.pone.0003148
   Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. P Natl Acad Sci USA. 2008;105:10513–10518. doi: 10.1073/pnas.0804549105
   PubMed Web of Science ®Google Scholar
• Kong L, Zhu J, Han W, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011;48:61–69. doi: 10.1007/s00592-010-0226-0
   PubMed Web of Science ®Google Scholar
• Goren Y KM, Zafrir B, Tabak S, et al. Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail. 2012:14; 147–154. doi: 10.1093/eurjhf/hfr155
   PubMed Web of Science ®Google Scholar
• Shi W, Du J, Qi Y, et al. Aberrant expression of serum miRNAs in schizophrenia. J Psychiatr Res. 2012;46:198–204. doi: 10.1016/j.jpsychires.2011.09.010
   PubMed Web of Science ®Google Scholar
• Ji F, Yang B, Peng X, et al. Circulating microRNAs in hepatitis B virus-infected patients. J. Viral Hepat.. 2011;18:e242–e251. doi: 10.1111/j.1365-2893.2011.01443.x
   PubMed Web of Science ®Google Scholar
• Chen L, Zhou Y, Sun Q, et al. Regulation of autophagy by MiRNAs and their emerging roles in tumorigenesis and cancer treatment. International Review of Cell & Molecular Biology. 2017;334:1–26. doi: 10.1016/bs.ircmb.2017.03.003
   PubMed Web of Science ®Google Scholar
• Matthew A, Sermersheim KHP, Kristyn Gumpper TM, et al. MicroRNA regulation of autophagy in cardiovascular disease. Frontiers in Bioscience. 2017;22:48–65. doi: 10.2741/4471
   Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol: Mech Dis. 2014;9:287–314. doi: 10.1146/annurev-pathol-012513-104715
   PubMed Web of Science ®Google Scholar
• Frankel LB, Lund AH. MicroRNA regulation of autophagy. Carcinogenesis. 2012;33:2018–2025. doi: 10.1093/carcin/bgs266
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol. 2010;22:124–131. doi: 10.1016/j.ceb.2009.11.014
   PubMed Web of Science ®Google Scholar
• Ponpuak M, Davis AS, Roberts EA, et al. Delivery of cytosolic components by autophagic adaptor protein p62 Endows autophagosomes with unique antimicrobial properties. Immunity. 2010;32:329–341. doi: 10.1016/j.immuni.2010.02.009
   PubMed Web of Science ®Google Scholar
• Ehlers S, Schaible UE. The granuloma in tuberculosis: Dynamics of a host–pathogen collusion. Front Immunol. 2013;3:411. doi: 10.3389/fimmu.2012.00411
   PubMed Web of Science ®Google Scholar
• Deretic V. Autophagy in tuberculosis. Cold Spring Harb Perspect Med. 2014;4:a018481–a018481. doi: 10.1101/cshperspect.a018481
   PubMed Web of Science ®Google Scholar
• Kroemer G. Autophagy: a druggable process that is deregulated in aging and human disease. J Clin Invest. 2015;125:1–4. doi: 10.1172/JCI78652
   PubMed Web of Science ®Google Scholar
• White E. The role for autophagy in cancer. J Clin Invest. 2015;125:42–46. doi: 10.1172/JCI73941
   PubMed Web of Science ®Google Scholar
• Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci. 2015;16:345–357. doi: 10.1038/nrn3961
   PubMed Web of Science ®Google Scholar
• Lavandero S, Chiong M, Rothermel BA, et al. Autophagy in cardiovascular biology. J Clin Invest. 2015;125:55–64. doi: 10.1172/JCI73943
   PubMed Web of Science ®Google Scholar
• Kim JK, Yuk J-M, Kim SY, et al. MicroRNA-125a inhibits autophagy activation and antimicrobial responses during mycobacterial infection. The Journal of Immunology. 2015;194:5355–5365. doi: 10.4049/jimmunol.1402557
   PubMed Web of Science ®Google Scholar
• Kim JK, Lee H-M, Park K-S, et al. MIR144* inhibits antimicrobial responses against mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2. Autophagy. 2016;13:423–441. doi: 10.1080/15548627.2016.1241922
   PubMed Web of Science ®Google Scholar
• Holla S, Kurowska-Stolarska M, Bayry J, et al. Selective inhibition of IFNG-induced autophagy by Mir155- and Mir31-responsive WNT5A and SHH signaling. Autophagy. 2014;10:311–330. doi: 10.4161/auto.27225
   PubMed Web of Science ®Google Scholar
• Romagnoli A, et al. ESX-1 dependent impairment of autophagic flux by mycobacterium tuberculosis in human dendritic cells. Autophagy. 2012;8:1357–1370. doi: 10.4161/auto.20881
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang H, Zhao Y, et al. Effects of mycobacterium tuberculosis ESAT-6/CFP-10 fusion protein on the autophagy function of mouse macrophages. DNA Cell Biol. 2012;31:171–179. doi: 10.1089/dna.2011.1290
   PubMed Web of Science ®Google Scholar
• Ministry of Health of the People's Republic of China. Diagnostic criteria for pulmonary tuberculosis.
   Google Scholar
• Wang C, Liu C-M, Wei L-L, et al. A group of novel serum diagnostic biomarkers for multidrug-resistant tuberculosis by iTRAQ-2D LC-MS/MS and solexa sequencing. Int J Biol Sci. 2016;12:246–256. doi: 10.7150/ijbs.13805
   PubMed Web of Science ®Google Scholar
• Enright AJ, John B, Gaul U, et al. MicroRNA targets in drosophila. Genome Biol. 2003;5:RI. doi: 10.1186/gb-2003-5-1-r1
   PubMed Web of Science ®Google Scholar
• Bjorkoy G, Lamark T, Brech A, et al. P62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 2005;171:603–614. doi: 10.1083/jcb.200507002
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3:542–545. doi: 10.4161/auto.4600
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdalla FC, Abeliovich H. Guidelines for the use and interpretation of assays for monitoring autophagy. autophagy. 2012;8:445–544. doi: 10.4161/auto.19496
   PubMed Web of Science ®Google Scholar
• Bardag-Gorce F, Francis T, Nan L, et al. Modifications in P62 occur due to proteasome inhibition in alcoholic liver disease. Life Sci. 2005;77:2594–2602. doi: 10.1016/j.lfs.2005.04.020
   PubMed Web of Science ®Google Scholar
• Lewis BP, Shih I, Jones-Rhoades MW, et al. Prediction of mammalian MicroRNA targets. cell. 2003;115:787–798. doi: 10.1016/S0092-8674(03)01018-3
   PubMed Web of Science ®Google Scholar
• Gutierrez MG, Master SS, Singh SB, et al. Autophagy is a defense mechanism inhibiting BCG and mycobacterium tuberculosis survival in infected macrophages. Cell. 2004;119:753–766. doi: 10.1016/j.cell.2004.11.038
   PubMed Web of Science ®Google Scholar
• Wang C, Yang S, Liu C-M, et al. Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis. Tuberculosis. 2018;108:26–34. doi: 10.1016/j.tube.2017.08.010
   PubMed Web of Science ®Google Scholar
• Zhou J. Early diagnosis of pulmonary tuberculosis using serum biomarkers. Proteomics. 2015;15:6–7. doi: 10.1002/pmic.201400532
   PubMed Web of Science ®Google Scholar
• van Rooij E, Purcell AL, Levin AA. Developing microRNA therapeutics. Circ Res. 2012;110:496–507. doi: 10.1161/CIRCRESAHA.111.247916
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li T, Chen G, et al. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p. Lung Cancer. 2017;114:6–11. doi: 10.1016/j.lungcan.2017.10.002
   PubMed Web of Science ®Google Scholar
• Kumar M, Sahu SK, Kumar R, et al. MicroRNA let-7 modulates the immune response to mycobacterium tuberculosis infection via control of A20, an inhibitor of the NF-κB pathway. Cell Host Microbe. 2015;17:345–356. doi: 10.1016/j.chom.2015.01.007
   PubMed Web of Science ®Google Scholar
• Ni B, Rajaram MVS, Lafuse WP, et al. Mycobacterium tuberculosis decreases human macrophage IFN-γ responsiveness through miR-132 and miR-26a. The Journal of Immunology. 2014;193:4537–4547. doi: 10.4049/jimmunol.1400124
   PubMed Web of Science ®Google Scholar
• Zhen Y, Li W. Impairment of autophagosome-lysosome fusion in the buff mutant mice with the VPS33AD251E mutation. Autophagy. 2015;11:1608–1622. doi: 10.1080/15548627.2015.1072669
   PubMed Web of Science ®Google Scholar
• Jiang P, Nishimura T, Sakamaki Y, et al. The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17. Mol Biol Cell. 2014;25:1327–1337. doi: 10.1091/mbc.e13-08-0447
   PubMed Web of Science ®Google Scholar
• Guo X, Tu L, Gumper I, et al. Involvement of Vps33a in the fusion of uroplakin-degrading multivesicular bodies with lysosomes. Traffic. 2009;10:1350–1361. doi: 10.1111/j.1600-0854.2009.00950.x
   PubMed Web of Science ®Google Scholar
• Yang W, Wang J, Chen Z, et al. NFE2 Induces miR-423-5p to promote gluconeogenesis and hyperglycemia by repressing the hepatic FAM3A-ATP-Akt pathway. Diabetes. 2017;66:1819–1832. doi: 10.2337/db16-1172
   PubMed Web of Science ®Google Scholar
• Daniel L, Clemens MAH. Characterization of the mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med. 1995;181: 257–270. doi: 10.1084/jem.181.1.257
   PubMed Web of Science ®Google Scholar
• Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol. 2012;12:352–366. doi: 10.1038/nri3211
   PubMed Web of Science ®Google Scholar
• Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev. 2015;264:182–203. doi: 10.1111/imr.12266
   PubMed Web of Science ®Google Scholar
• Giosue S, Casarini M, Ameglio F, et al. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis. Eur Cytokine Netw. 2000;11:99–103.
   PubMed Web of Science ®Google Scholar
• Liu B, Fang M, Hu Y, et al. Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation. Autophagy. 2013;10:416–430. doi: 10.4161/auto.27286
   PubMed Web of Science ®Google Scholar
• Yang Z-S, Ma L-Q, Zhu K, et al. Pseudomonastoxin pyocyanin triggers autophagy: Implications for pathoadaptive mutations. Autophagy. 2016;12:1015–1028. doi: 10.1080/15548627.2016.1170256
   PubMed Web of Science ®Google Scholar
• Deretic V. Autophagy in innate and adaptive immunity. Trends Immunol. 2005;26:523–528. doi: 10.1016/j.it.2005.08.003
   PubMed Web of Science ®Google Scholar